We are live on ! Find out more
Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Portfolio holdings

AUM $59.8B
1-Year Est. Return 29.42%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$38.7B
AUM Growth
+$4.24B
Cap. Flow
+$1.61B
Cap. Flow %
4.15%
Top 10 Hldgs %
23.45%
Holding
2,603
New
262
Increased
1,190
Reduced
917
Closed
122
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRT icon
2326
CALL
Vertiv
VRT
$105B
$69.8K ﹤0.01%
+2,500
New +$157K
MSFT icon
2327
CALL
Microsoft
MSFT
$3.76T
$69.5K ﹤0.01%
1,200
+1,100
+1,100% +$445K
DXLG icon
2328
Destination XL Group
DXLG
$33M
$67.8K ﹤0.01%
18,832
-206
-1% -$808
TTI icon
2329
TETRA Technologies
TTI
$1.27B
$67.8K ﹤0.01%
15,300
-1,428
-9% -$5.93K
AEF
2330
abrdn Emerging Markets Equity Income Fund
AEF
$365M
$65.5K ﹤0.01%
12,974
-29,051
-69% -$145K
AVGO icon
2331
CALL
Broadcom
AVGO
$2.01T
$65.4K ﹤0.01%
+6,000
New +$743K
MNKD icon
2332
MannKind Corp
MNKD
$1.28B
$65.4K ﹤0.01%
14,429
+77
+0.5% +$302
PACB icon
2333
Pacific Biosciences
PACB
$354M
$58.4K ﹤0.01%
15,577
-897
-5% -$5.25K
BCRX icon
2334
BioCryst Pharmaceuticals
BCRX
$2.46B
$57.2K ﹤0.01%
+11,261
New +$63.3K
GENI icon
2335
Genius Sports
GENI
$2.08B
$57.1K ﹤0.01%
10,000
CCO icon
2336
Clear Channel Outdoor Holdings
CCO
$1.23B
$56.8K ﹤0.01%
34,447
RNLX
2337
DELISTED
Renalytix plc American Depositary Shares
RNLX
$54.8K ﹤0.01%
63,739
+44,126
+225% +$30.2K
LLY icon
2338
CALL
Eli Lilly
LLY
$1.09T
$54K ﹤0.01%
500
-1,500
-75% -$1.07M
TLRY icon
2339
Tilray
TLRY
$595M
$51.6K ﹤0.01%
2,090
-26
-1% -$501
TWOU
2340
DELISTED
2U Inc
TWOU
$51.1K ﹤0.01%
4,372
-10
-0.2% -$195
ADAP
2341
DELISTED
Adaptimmune Therapeutics
ADAP
$50.9K ﹤0.01%
32,239
CLOV icon
2342
Clover Health Investments
CLOV
$2.44B
$50.4K ﹤0.01%
63,465
+135
+0.2% +$123
SABR icon
2343
Sabre
SABR
$823M
$49.9K ﹤0.01%
20,628
+2,592
+14% +$8.7K
HYPR icon
2344
Hyperfine
HYPR
$102M
$49.9K ﹤0.01%
49,915
SKE
2345
Skeena Resources
SKE
$4.07B
$48.9K ﹤0.01%
+10,594
New +$44.7K
VRTX icon
2346
CALL
Vertex Pharmaceuticals
VRTX
$134B
$46.6K ﹤0.01%
1,400
-3,100
-69% -$1.31M
GALT icon
2347
Galectin Therapeutics
GALT
$317M
$44.5K ﹤0.01%
18,639
MJ icon
2348
Amplify Alternative Harvest ETF
MJ
$104M
$42.8K ﹤0.01%
854
-566
-40% -$23.9K
MIN
2349
Aberdeen Intermediate Income Fund
MIN
$278M
$41.2K ﹤0.01%
15,500
AMZN icon
2350
CALL
Amazon
AMZN
$2.99T
$41.2K ﹤0.01%
1,000
-500
-33% -$83.5K

Similar funds

Wealth Enhancement Advisory Services's Q1 2024 Portfolio in Review

As of Q1 2024, Wealth Enhancement Advisory Services held 2,603 positions worth $38.7B, up 12% from $34.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Wealth Enhancement Advisory Services deployed $1.61B of net new capital in Q1 2024, opening 262 new positions and adding to 1,190 existing holdings. Its largest new stake was ALPS Smith Core Plus Bond ETF: 19,926,994 shares worth $511M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street DoubleLine Total Return Tactical ETF, an estimated $409M trimmed.

  • Wealth Enhancement Advisory Services's largest Q1 2024 buy was ALPS Smith Core Plus Bond ETF: 19,926,994 shares worth $511M.
  • Wealth Enhancement Advisory Services added most to JPMorgan US Momentum Factor ETF in Q1 2024, an estimated $377M increase.
  • Wealth Enhancement Advisory Services's biggest Q1 2024 reduction was State Street DoubleLine Total Return Tactical ETF, cutting an estimated $409M.
  • Wealth Enhancement Advisory Services fully exited JPMorgan Short Duration Core Plus ETF in Q1 2024, selling an estimated $26.5M.
  • Wealth Enhancement Advisory Services's ten largest holdings make up 23% of its $38.7B portfolio in Q1 2024.
  • Wealth Enhancement Advisory Services opened 262 new positions and closed 122 in Q1 2024.
  • Wealth Enhancement Advisory Services's portfolio value rose 12% quarter-over-quarter to $38.7B.

Based on Wealth Enhancement Advisory Services's 13F filing for Q1 2024, filed 15 Apr 2024.